Novavax Inc vs TKO Group Holdings Inc — how do they compare? Novavax Inc trades at $8.06 (market cap $1.30B), while TKO Group Holdings Inc trades at $181.83 (market cap $13.70B). The key difference: TKO Group Holdings Inc is far larger — about 10.5× Novavax Inc's market cap, and TKO Group Holdings Inc pays a 1.7% dividend while Novavax Inc pays none. Which is the better fit depends on your goals.
| NVAX | TKO | |
|---|---|---|
Market Cap | $1.30B | $13.70B |
Sector | Health | Technology |
52-Week High | $11.19 | $224.96 |
52-Week Low | $6.22 | $155.61 |
Enterprise Value | $800.50M | $17.88B |
Dividend Yield | — | 1.7% |
Trailing returns across standard periods
Latest headlines on both assets
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →